Search results
Climate Change Is a Worse Health Threat Than We Think | by Manica Balasegaram - Project Syndicate
Project Syndicate· 9 hours agoManica Balasegaram warns that the world is underestimating the extent to which global warming will...
Medical school scientist creates therapy to kill hypervirulent bacteria
Science Daily· 10 hours agoIn a study published recently in Cell Reports Physical Science, Fleeman showed that an antimicrobial peptide from cows has potential for treating incurable infections from the bacterium Klebsiella ...
Alarming superbug from deadly eyedrop outbreak has spread to dogs
Ars Technica· 21 hours agoThe two dogs in New Jersey were not known to have received the drops linked to the outbreak:...
Delphia starts up with $67M to make a new type of cancer drug
BioPharma Dive via Yahoo Finance· 10 hours agoDelphia is developing medicines designed to overstress certain cellular pathways to the point tumor...
Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapy
Medical Xpress· 22 hours agoThe findings are published in Nature Communications. Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. The researchers studied resistance variants found in the non-coding ...
UTIs make life miserable — scientists are finding new ways to tackle them
Nature· 17 hours agoResearchers are developing vaccines and fresh drug approaches to prevent and treat recurring...
Altamira Therapeutics files new RNA delivery patent By Investing.com
Investing.com· 1 day agoAltamira Therapeutics Ltd. (NASDAQ:CYTO), a biopharmaceutical company focusing on RNA delivery...
AAV-vectored expression of monospecific or bispecific monoclonal antibodies protects mice from...
Nature· 5 days agoPseudomonas aeruginosa poses a significant threat to immunocompromised individuals and those with cystic fibrosis. Treatment relies on antibiotics, but persistent infections occur due to intrinsic ...
Deciphera Pharmaceuticals (NASDAQ:DCPH) Given “Neutral” Rating at Guggenheim
ETF DAILY NEWS· 7 hours agoDeciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at Guggenheim in a research note issued on Tuesday, Benzinga reports. Several ...
Experts develop immune-enhancing therapies to target tuberculosis
Medical Xpress· 6 days agoExperts are working on novel immune-enhancing therapies called host-directed therapies to use the...